Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Stuttgart - Delayed Quote • EUR Belite Bio Inc (D01.SG) Follow Add holdings 54.50 +1.50 +(2.83%) At close: 9:26:35 PM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for D01.SG 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: D01.SG View More All News Press Releases SEC Filings Belite Bio Announces Poster Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting Belite Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results Belite Bio to Participate in the Leerink Partners Global Healthcare Conference Belite Bio Announces Interim Analysis Results from the Pivotal Global Phase 3 DRAGON trial of Tinlarebant in Adolescent Stargardt Disease Subjects Belite Bio Announces Registered Direct Offering of $15 Million Breakeven On The Horizon For Belite Bio, Inc (NASDAQ:BLTE) Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007 Belite Bio Reports Third Quarter 2024 Financial Results and Provides a Corporate Update Belite Bio to Host Webcast on November 12, 2024, to Discuss Third Quarter 2024 Financial Results Related Tickers A71.F Ascendis Pharma A/S 146.00 +0.69% ATQP.F Vericel Corporation 33.40 -1.76% PTCT PTC Therapeutics, Inc. 49.95 +0.87% SLNO Soleno Therapeutics, Inc. 75.23 +0.28% PRTG Portage Biotech Inc. 10.27 -4.55%